Treatment of 140 cerebral palsied children with a combined method based on traditional Chinese medicine(TCM)and western medicine

Objective:To observe and evaluate a method that is effective and practical for treatment of cerebral palsied(CP)children in China.Method:The patient's age and disease type and individual specific conditions were considered in choosingtherapy methods accordingly:Chinese herbs,acupuncture,auricnlar seed pressure,point finger pressing,massage,orthopedichand manipulation,physiotherapy,occupational therapy,language therapy,etc.Meanwhile we created a new CP treatment modelthat combines hospitalized treatment with family therapy.Results:The majority of CP patients improved greatly in motor andsocial adaptation capacities after treatment.Wilcoxon paired rank sum test analysis showed that there were significant differencesbetween the data before and after treatment(P<0.01).Conclusion:This combined therapy method,based on traditional Chinesemedicine and western medicine plus family supplemental therapy,is an effective and practical treatment strategy for CP children inChina.

Evaluation of Clinical Efficacy on Acute Pancreatitis Treated with Combination of Traditional Chinese and Western Medicine: A Meta-Analysis

Objective: Meta-analysis was conducted to assess whether combination of traditional Chinese and western medicine could enhance clinical outcomes compared to single western medicine in the treatment of acute pancreatitis (AP). Methods: This systematic review will include prospective and retrospective comparative studies in all languages and evaluate the clinical efficacy of integrated traditional Chinese and western medicine versus single western medicine in treatment AP. Animal studies will not be considered. Published articles were acquired from Jan. 2001 to Dec. 2017 by a comprehensive search in Chinese National Knowledge Infrastructure database (CNKI), Chinese WANFANG database. Exclusion criteria were non-comparative studies, hybrid treatment. The main points include clinical efficacy;carefully evaluating and reviewing the literature and filtering the literature according to inclusion criteria and exclusion criteria. Statistical analyses were performed using software Review Manager (Version 5.0). Publication biases of main results were examined by Stata 12.0. Results: 1262 cases of 1342 cases were effective and the effective rate reaches 94.04% in the group of integrated traditional Chinese and western medicine, while 949 cases of 1223 cases were effective and its effective rate can be up to 77.60% in the group of single western medicine (P > 0.05%, I2 = 0%, Odds Ratio (OR) = 4.98, 95% CI = 3. 79 - 6.54, P Conclusion: These results suggest that the therapeutic effects of integrated traditional Chinese and Western medicine on AP are better in treatment of AP than that of western medicine alone.

Nursing perspective of expert consensus on the diagnosis and treatment of cerebral infarction with integrated traditional Chinese and Western medicine

Cerebral infarction(CI)is also known as ischemic stroke.It is one of the most common cerebrovascular diseases,with high mortality and disability rate,which has seriously threatened human health.To better apply the diagnosis and treatment plan of integrated traditional Chinese and Western medicine to the treatment of patients with CI,the Chinese Association of Integrative Medicine issued the Expert Consensus on the Diagnosis and Treatment of Cerebral Infarction with the Integrated Traditional Chinese and Western Medicine in 2021.It involves etiology and pathogenesis of CI,diagnosis and treatment standards of Traditional Chinese Medicine(TCM)and Western Medicine,syndrome elements of TCM,as well as rehabilitation nursing of CI with integrated traditional Chinese and Western medicine during acute period and recovery period.This study interprets the consensus from routine nursing,dietary nursing,emotional nursing,complication nursing,rehabilitation nursing,and continuous nursing,aiming to provide evidence-based support for clinical TCM nursing practice.

Clinical Observation of Integrated Traditional Chinese and Western Medicine in the Treatment of Chronic Ulcerative Rectitis

Objective:To observe and compare whether the combination of traditional Chinese and Western medicine can achieve more satisfactory results in the treatment of patients with chronic ulcerative rectitis(UR).Methods:70 cases of chronic ulcerative rectitis were selected in all hospitals of our hospital for comparison.Observation and control were set up.The number of people was the same,but there were differences in methods.The control group retained enema,and the observation group was treated with traditional Chinese medicine.Rectal mucosa scores after different treatments were compared to evaluate the effect of intervention.Results:It was found that the observation group scored lower(P<0.05),and the effect was better.Conclusion:For the treatment of patients with chronic ulcerative rectitis,the combination of traditional Chinese and Western medicine will help to promote the prognosis of the disease,improve the problem of ulcer,promote the improvement of gastrointestinal function and bring a more positive impact.

Meta-analysis of traditional Chinese medicine and western medicine in treating retinal vein occlusion complicated by macular edema

Objective:TMeta-analysis was performed to evaluate the clinical efficacy of the combination of traditional Chinese medicine and western medicine in treating patients with retinal vein occlusion(RVO)complicated by macular edema(ME).Methods:We searched The CNKI,Wanfang Data,PubMed and Cochrane Library from database.All of randomized controlled trials(RCTs)of the combination of traditional Chinese medicine and western medicine in treating patients with RVO complicated by ME were searched.The Revman5.3 software were used for meta-analysis.Results:A total of 30 trials involving 1943 patients and 1976 eyes were included.Meta-analysis showed that compared with western medicine,the combination of traditional Chinese medicine and western medicine can significantly improve the best corrected visual acuity[(MD=0.08,95%CI=0.07~0.10,P<0.00001)(MD=-0.16,95%CI=-0.24^-0.08,P=0.0002)(MD=5.78,95%CI=1.30~10.25,P=0.01)],reduce the central macular thickness(MD=-54.6,95%CI=-73.76^-35.43,P<0.00001),and improve the clinical effective rate(RR=1.32,95%CI=1.22~1.43,P<0.00001).Conclusion:The combination of traditional Chinese and western medicine in treating patients with RVO complicated by ME was superior to western medicine in improving the best corrected visual acuity,reducing the thickness of macular fovea and improving the clinical efficacy.

Meta-analysis on the treatment of adenoid hypertrophy in children with integrated traditional Chinese and western medicine

Objective: To evaluate the effect of combined Chinese and western medicine on children withadenoidal hypertrophy. Methods: System comprehensive retrieve hownet (CNKI), a database of ten thousand China (WanFang), Chinese biomedical database (CBM), weipu database (VIP), PubMed, Embase and Cochrane library database, retrieval time from March 1, 2009 to December 31, 2019, the use of "Cochrane bias risk assessment tools to have included in the quality of literature evaluation, and to use the literature on into RevMan 5.3 software for Meta quantitative analysis. A total of 10 references were included in this study, and a total of 464 clinical cases were included in the total sample size for meta-analysis, including 242 in the experimental group and 222 in the control group. Results: The statistical data show that the total effective rate of combined traditional Chinese and western medicine for the treatment of adenoid hypertrophy in children is higher than that of western medicine alone (OR = 4.27, 95% CI: 2.50, 7.13, P <0.00001) The effect of nasal congestion caused by adenoid hypertrophy in children is better than that of western medicine alone (MD =-0.64, 95% CI [-0.94, -0.35], P <0.0001);the effect of improving snoring symptoms in children Better than using western medicine alone, the difference is statistically significant (MD =-0.66, 95% CI [-1.11, -0.21], P <0.01);the effect of reducing the relative ratio of adenoid and posterior nostril is better than that of pure The difference was statistically significant when treated with Chinese or Western medicine (MD =-0.18, 95% CI [-0.24, -0.12], P <0.00001). Conclusion: Based on the existing data and methods, traditional Chinese medicine combined with western medicine has a reliable effect on adenoid hypertrophy in children. It is superior to western medicine alone in terms of treatment efficiency and improvement of clinical symptoms, without serious adverse reactions.

Clinical Effect of Integrated Traditional Chinese and Western Medicine on Diabetic Peripheral Neuropathy

Objective:Patients with diabetic peripheral neuropathy were treated with integrated traditional Chinese and western medicine,and the final results were observed.Methods:70 patients with such symptoms were randomly divided into two groups.The number of people is the same,and the treatment methods are different.The control group uses western medicine,while the observation group uses traditional Chinese medicine to evaluate the treatment effect.Results:After treatment,the effective rate of the observation group was(P<0.05),indicating that the treatment effect was significantly better.Conclusion:Patients with clinical diabetic peripheral neuropathy treated with routine nutrition and nerve repair,and with Chinese medicine,the effect is more satisfactory,and the effect is positive,so as to promote the optimization of their health.

Etiology and Pathogenesis of Pericarditis from the Perspective of Traditional Chinese and Western Medicine

Pericarditis is a common clinical pericardial disease with complex etiology,pathogenesis,and high recurrence rate.Interleukin-1 is an important inflammatory cytokine,which regulates the occurrence and development of inflammation by regulating IL-1α,IL-1β,and IL-IRA;it plays an important role in pericarditis.In traditional Chinese medicine,the modem understanding of its etiology and pathogenesis has been improved.In this review,the etiology and pathogenesis of pericarditis are discussed from the perspective of traditional Chinese and Western medicine.

Therapeutic effect of traditional Chinese medicine on coagulation disorder and accompanying intractable jaundice in hepatitis B virus-related liver cirrhosis patients

AIM： TO observe the therapeutic effects of new traditional Chinese medicine （TClVl） therapy on coagulation disorder and accompanying intractable jaundice in HBV-related liver cirrhosis patients. METHODS： Using stratified random sampling according to fibrinogen （Fib） levels, 145 liver cirrhosis patients due to hepatitis B complicated by coagulation disorder were treated. Of them, 70 in research group were treated with TCM by ＂nourishing yin, cooling blood and invigorating blood circulation＂ and Western medicine, 75 in control group were treated with conventional Western medicine. The indexes of liver function, coagulation function and bleeding events were observed and compared. RESULTS： The prothrombin time （PT） was shorter and the fibrinogen （Fib） level was higher in the research group than in the control group （Fib = 1.6-2.0 g/L, 1.1-1.5 g/L, and ≤ 1.0 g/L）. The total bilirubin （TBIL） level was significantly lower in the research group than in the control group, except for the subgroup of FIB ≤ 1.0 g/L. CONCLUSION： TCM therapy can improve coagulation fuction and decrease TBIL.

meta-analysis of randomized controlled trials of combined treatment with DGSN and western medicine on diabetic peripheral neuropathy

Objective:To systematically study the clinical effects of combined treatment with Dang gui si ni tang(DGSN)and western medicine(WM)on diabetic peripheral neuropathy.Methods:Seven databases,including Chinese National Knowledge Infrastructure(CNKI),Chinese Biomedical Database(CBM),Wanfang full-text database,VIP Database for Chinese Technical Periodicals,MEDLINE,PubMed,Embase,were retrieved.Related references about randomized controlled trials on the combination of DGSN and WM on diabetic peripheral neuropathy published during January 2012 up to now(recent 5 years)were reviewed.Related grey literatures were also reviewed according to the selected articles.RevMan5.3 software was used to analyze the publish bias,and to compare the total clinical effects of the combination of DGSN and WM with WM alone.Results:Ultimately,19 randomized controlled trials with 1690 patients were incorporated.The results of meta-analysis showed that combined treatment of diabetic peripheral neuropathy with DGSN and WM showed better general efficacy compared with control group,with a statistically significant difference(P<0.05).The results of study showed homogeneity(P=0.94>0.05).The general efficacy of combined treatment with DGSN and WM was significantly higher than that of control group(P<0.00001,OR=3.98,95%CI:3.01~5.27).Conclusion:Compared with treatment with WM alone,combined treatment of diabetic peripheral neuropathy with DGSN and WM is more effective.Meanwhile,due to the limited literature samples and low quality of literatures,large samples and high quality of multi-center randomized controlled double-blind trials are needed to verify these results.

Treatment of Helicobacter pylori-associated gastritis using traditional Chinese medicine

Helicobacter pylori is a pathogenic bacterium with strong pathogenicity, which can induce chronic gastritis and peptic ulcer in addition to causing gastric mucosal atrophy and intestinal metaplasia after longterm infection. It is even associated closely with the occurrence of gastric cancer and mucosa-associated lymphoid tissue lymphoma. Recently, the incidence of H. pylori-associated gastritis has increased rapidly worldwide, especially in China. The prevention and treatment of H. pylori infection has become an urgent issue to be resolved by the medical community. Traditional Chinese medicine and the combination of traditional Chinese medicine and Western medicine have recently shown unique advantages in the treatment of H. pylori–associated gastritis. The progress in this area is summarized in this review.

Cohort Study on the Effect of a Combined Treatment of Traditional Chinese Medicine and Western Medicine on the Relapse and Metastasis of 222 Patients with Stage Ⅱ and Ⅲ Colorectal Cancer after Radical Operation

Objective： To evaluate the effectiveness of a comprehensive therapy of traditional Chinese medicine （TCM） in reducing the relapse and metastasis of stage Ⅱ and Ⅲ colorectal cancer based on conventional Western medicine （WM） therapy. Methods： Two hundred and twenty-two patients in total, diagnosed as stage Ⅱ and Ⅲ colorectal cancer from February 2000 to March 2006, were recruited from Xiyuan Hospital, China Academy of Chinese Medical Sciences and the General Hospital of Beijing Military Area. They were followed-up once every 3-6 months. Twenty cases dropped out from the cohort. The remaining 202 patients were all treated with routine WM treatment [including R0 radical operation, or chemotherapy or/and radiotherapy according to national comprehensive cancer network （NCCN） clinical guidelines]. These patients were assigned to two groups based on whether or not they were additionally treated with TCM comprehensive therapy （orally administered with a decoction according to syndrome differentiation, combined with a traditional patent drug over one year）. Ninety-eight patients from Xiyuan Hospital were treated with WM and TCM （combined group）, and 104 patients from the General Hospital of Beijing Military Area were treated with WM alone （WM group）. The demographic data at baseline were comparable, including the operation times, age, sex, TNM staging, and pathological types. The patients were followed-up for one to five years. Up to now, there are 98, 98, 77, 64, and 47 patients with 1, 2, 3, 4, and 5 years of follow-up in the combined group, respectively; and 104, 104, 97, 81, and 55 patients in the WM group, respectively. The results of the 5-year follow-up of all the patients will be available in 2011. Results： The relapse/metastasis rate of 1-, 2-, 3-, 4-, and 5-year were 0 （0/98）, 2.04% （2/98）, 11.69% （9/77）, 14.06% （9/64）, and 21.28% （10/47） in the combined group, and were 4.80%（5/104）, 16.35% （17/104）, 21.65% （21/97）, 25.93% （21/81）, and 38.18%（21/55） in the WM group, respectively. A significant difference was found in the second year between the two groups （X^2=12.117, P = 0.000）. Median relapse/metastasis time was 26.5 months in the combined group and 16.0 months in the WM group. Conclusion： The combined therapy of TCM and WM may have great clinical value and a potential for decreasing the relapse or metastasis rate in stage Ⅱ and Ⅲ colorectal cancer after conventional WM therapy.

Effect of Western medicine therapy assisted by Ginkgo biloba tablet on vascular cognitive impairment of none dementia

Objective:To discuss the clinical effects of Western medicine therapy assisted by Ginkgo biloba tablet(GBT) on patients with vascular cognitive impairment of none dementia(VCIND).Methods: A total of 80 patients with VCIND were divided into two groups randomly:Conventional treatment group(control group) and combined treatment group.Conventional treatment group was given conventional treatment with anti-platelet aggregation.In this group,75 mg aspirin was given three times a day for 3 months.While in combined treatment group,19.2 mg CRT was given three times a day for 3 months together with conventional treatment(anti-platelet aggregation drugs). Montreal cognitive assessment(MoCA) and transcranial Doppler(TCD) were used to observe changes of cognitive ability and cerebral blood flow in VCIND patients before and after treatment in both groups.Then the clinical data were analyzed so as to compare the efficacy in two groups. Results:After 3 month-treatment in combined treatment group,the scores of executive ability, attention,abstract,delayed memory,orientation in the MoCA were significantly increased compared with those before treatment and those in control group after treatment.Besides,blood flow velocity of anterior cerebral artery increased significandy than that before treatment and that in control group after treatment.Conclusions:CBT tablet can improve the therapeutic efficacy as well improve cognitive ability and cerebral blood flow supply of patients with VCIND.

Combined Treatment of Advanced Primary Hepatocellular Carcinoma with Traditional Chinese Medicine and Western Medicine

Ｃｏｍｂｉｎｅｄ Ｔｒｅａｔｍｅｎｔ ｏｆ Ａｄｖａｎｃｅｄ Ｐｒｉｍａｒｙ Ｈｅｐａｔｏｃｅｌｌｕｌａｒ Ｃａｒｃｉｎｏｍａ ｗｉｔｈ Ｔｒａｄｉｔｉｏｎａｌ Ｃｈｉｎｅｓｅ Ｍｅｄｉｃｉｎｅ ａｎｄ Ｗｅｓｔｅｒｎ ＭｅｄｉｃｉｎｅＹＵＥｒ－ｘｉ...

基于数据挖掘的胆石症动物模型特点及应用分析

目的对现有胆石症动物模型进行整理归纳,探索可更好反映中西医临床病证特点,满足中医药临床与基础研究发展需要的动物模型。方法检索中国知网、万方、维普、SinoMed、PubMed等数据库,对国内外胆石症相关实验研究的动物模型进行搜集和整理,对模型的动物种类、造模方法、造模周期、检测指标和阳性药等数据进行统计和分析。结果纳入的128篇文献中,胆石症模型的动物种类以豚鼠、家兔和C57BL/6小鼠为主。使用最多的造模方法为高脂饲料法,饲料喂养周期集中在8周。高频检测指标为成石率、总胆固醇、磷脂、总胆红素、总胆汁酸等。较多使用的干预方式为中药复方、西药和单味中药或提取物,西药干预以熊去氧胆酸(Ursodeoxycholic acid,UDCA)为主,中药干预以中药复方为主,还包括针灸、运动、饮食等其他干预方式。实验设立阳性对照药多为UDCA。结论随着胆石症动物模型的不断完善和发展,目前有较多种造模方法都较好地模拟了胆石症中西医临床表现特点,但也存在一定局限性。该文分析结果可为胆石症模型的选择、应用和完善提供参考。

柴胡加龙骨牡蛎汤联合艾司西酞普兰对卒中后抑郁患者神经功能、抑郁状态和血清脑源性神经营养因子、5-羟色胺水平的影响

目的观察柴胡加龙骨牡蛎汤联合艾司西酞普兰对卒中后抑郁(PSD)患者神经功能、抑郁状态及血清脑源性神经营养因子(BDNF)、5-羟色胺(5-HT)水平的影响。方法将98例PSD患者按照随机数字表法分为治疗组和对照组,各49例。对照组予草酸艾司西酞普兰片治疗6周,治疗组在对照组治疗基础上加柴胡加龙骨牡蛎汤治疗6周。比较2组疗效及治疗前、治疗3周和治疗6周美国国立卫生研究院卒中量表(NIHSS)评分和血清5-HT、BDNF水平。结果治疗组总有效率87.76%(43/49),对照组总有效率69.39%(34/49),治疗组总有效率高于对照组(P<0.05)。2组治疗3、6周NIHSS、HAMD评分均显著低于本组治疗前(P<0.05),治疗6周NIHSS和HAMD评分均显著低于本组治疗3周(P<0.05);治疗3、6周治疗组NIHSS和HAMD评分均显著低于对照组同期(P<0.05)。2组治疗3、6周5-HT、BDN水平均显著高于本组治疗前(P<0.05),治疗6周5-HT、BDNF水平均显著高于本组治疗3周(P<0.05);治疗3、6周治疗组5-HT和BDNF水平显著高于对照组同期(P<0.05)。结论柴胡加龙骨牡蛎汤联合艾司西酞普兰能改善PSD抑郁状态、神经功能及血清BDNF、5-HT水平。

近5年中西医治疗小儿抽动秽语综合征的可视化分析

目的 探索发现国内近5年中西医治疗的小儿抽动秽语综合征(TS)的热点话题和发展情况。方法 检索中国知网、万方、维普数据库中2018—2022年中西医结合治疗TS的相关文献。使用CiteSpace软件对关键词绘制知识图谱并进行分析。结果 共纳入342篇相关文献,每年发文量稳定在60篇以上。关键词135个,其中频次≥5的关键词21个。该领域的研究热点包括神经递质、免疫因素、中医药治疗、临床疗效及不良反应。结论 近5年中西医治疗TS的临床对照试验较多,但涉及低频重复经颅磁刺激、行为干预疗法的研究较少,缺乏大规模、多中心、随机双盲的研究,该领域的试验研究较少,且试验研究偏向于神经递质、神经电生理领域的研究,从基因、免疫学角度探讨TS较少,研究的深度与广度均有待加强。

中西医结合治疗重症肺炎机械通气患者的疗效及对脱机效果的影响

目的探讨中西医结合治疗重症肺炎机械通气患者的疗效及对脱机效果的影响。方法选取2020年1月至2022年9月于滕州市中医医院接受机械通气治疗的108例重症肺炎患者作为研究对象,按照随机数字表法分为对照组与研究组,各54例。对照组采用机械通气治疗与常规药物治疗,研究组在对照组基础上开展中西医结合治疗。比较两组机械通气时间、住院时间、潮气量、CO_(2)分压、呼吸频率、心率、临床疗效、脱机成功情况及呼吸机相关性肺炎(VAP)发生情况。结果研究组机械通气时间、住院时间均短于对照组,差异有统计学意义(P<0.05);治疗后,两组潮气量高于治疗前,CO_(2)分压、呼吸频率及心率均低于治疗前,且研究组潮气量高于对照组,CO_(2)分压、呼吸频率及心率均低于对照组,差异有统计学意义(P<0.05);研究组治疗总有效率高于对照组,差异有统计学意义(P<0.05);研究组脱机成功率高于对照组,VAP发生率低于对照组,差异有统计学意义(P<0.05)。结论中西医结合治疗重症肺炎机械通气患者疗效显著,可缩短患者的机械通气与住院时间,改善脱机效果,且安全性较高,值得临床推广应用。

中药脐疗治疗溃疡性结肠炎缓解期疗效观察

目的观察中药脐疗干预治疗溃疡性结肠炎缓解期临床效果。方法选取2021年1月至2023年3月在潍坊医学院附属高密市人民医院消化内科就诊溃疡性结肠炎缓解期患者,按照随机数表法分为治疗组、对照组,每组各35例。对照组口服美沙拉嗪肠溶片1.0 g,tid;治疗组同时给予中药脐疗“十味抗炎方”凝胶剂。采用改良Mayo评分评价溃疡性结肠炎严重程度;溃疡性结肠炎疾病活动指数评价疾病活动度;炎症性肠病生存量表评价生存质量;检查炎症因子白细胞介素-6、白细胞介素-8和肿瘤坏死因子-α;选择抑郁自评量表和焦虑自评量表评价患者心理情况。结果治疗组第5、6个月Mayo评分和疾病活动指数得分低于对照组,差异有统计学意义(P<0.05);治疗组第3、4、5、6个月炎症性肠病生存量表得分高于对照组,差异有统计学意义(P<0.05);治疗组第3、6个月炎症因子低于对照组,差异有统计学意义(P<0.05);治疗组第3、6个月抑郁和焦虑自评量表评分低于对照组,差异有统计学意义(P<0.05)。结论中药脐疗提升患者生活质量,改善预后,临床疗效优于对照组。

中西医结合治疗脑卒中后顽固性呃逆临床观察

目的 探讨中西医结合治疗脑卒中后顽固性呃逆的临床疗效。方法 100例脑卒中后顽固性呃逆患者,应用随机数字表法分为研究组与对照组,各50例。对照组患者采用甲氧氯普胺治疗,研究组患者采用甲氧氯普胺联合中药方剂丁香柿蒂汤治疗。对比两组疗效,不良反应发生率,治疗前后的舒适度评分、心理评分、睡眠状况指标、生活质量评分。结果 研究组治疗总有效率为96.00%,对照组为82.00%,研究组治疗总有效率更高(P<0.05)。研究组中发生2例恶心、1例腹痛,不良反应发生率为6.00%;对照组中发生1例皮疹,不良反应发生率为2.00%。两组不良反应发生率对比,差异无统计学意义(P>0.05)。治疗后,两组舒适度评分、焦虑评分、抑郁评分均较治疗前改善,且研究组舒适度评分(102.80±6.57)分高于对照组的(93.25±6.30)分,焦虑评分(40.90±3.74)分、抑郁评分(41.85±3.81)分低于对照组的(45.61±3.96)、(46.98±4.37)分(P<0.05)。治疗后,两组入睡潜伏期、实际睡眠时长、睡眠质量评分均较治疗前改善,且研究组入睡潜伏期(33.79±7.94)min短于对照组的(42.63±8.75)min,实际睡眠时长(8.04±1.13)h长于对照组的(6.89±1.02)h,睡眠质量评分(10.80±1.31)分低于对照组的(12.56±1.58)分(P<0.05)。治疗后,两组生理、心理、环境、社会关系评分均较治疗前改善,且研究组生理、心理、环境、社会关系评分分别为(89.75±6.48)、(89.07±6.02)、(90.14±6.15)、(89.96±6.27)分,高于对照组的(82.93±6.85)、(82.40±6.13)、(83.27±6.30)、(83.14±6.54)分(P<0.05)。结论 对于脑卒中后顽固性呃逆患者,采用甲氧氯普胺联合中药汤方丁香柿蒂汤的中西医结合疗法可增强治疗效果,提高患者舒适度,有利于改善患者心理、睡眠等状况,提升其生活质量,且不会在用药后增加药物不良反应,安全性良好。